Diabetomics, Inc. is a global medical diagnostics company based in Lake Oswego, OR, specializing in the development of innovative, non-invasive point-of-care tests. Their pioneering products include Lumella, the first and only point-of-care tests for early detection of preeclampsia and gestational diabetes, and Insudex, the first and only point-of-care tests for early detection of type-1 diabetes and LADA (Latent Autoimmune Diabetes in Adults).
Additionally, Diabetomics offers Glucema, the first and only point-of-care saliva test for diabetes monitoring, and RAprime, the first and only rapid point-of-care test for detection of rheumatoid arthritis. The company is committed to alleviating the economic and public health burden of maternal health and diabetes through their cutting-edge diagnostic solutions.
Generated from the website